Prescription medical cannabis has been legal in the UK since November 2018, and yet a large number of people who might truly benefit from it still have very little idea how to access it. That gap between what’s technically available and what patients actually know about is one of the more frustrating aspects of how it has rolled out.
The NHS can prescribe cannabis-based medicines, but in practice it almost never does. The criteria are extremely narrow, the pathway is slow, and most GPs will tell you quite honestly that they’re not in a position to prescribe it themselves. That’s left a lot of patients either going without, or turning to private clinics that specialise in exactly this area, which is where things get a bit more interesting.
Who Tends to Seek It Out
The profile of someone seeking a medical cannabis prescription isn’t what a lot of people imagine; it’s not exclusively young people or those with a background in recreational use. Plenty of patients are in their 50s, 60s, and older, dealing with chronic pain and conditions that haven’t responded well to conventional treatments, while others are managing anxiety disorders, PTSD, and sleep problems that have had a major impact on their daily lives for years.
Chronic pain is probably the most common reason patients go down this route. Conditions like fibromyalgia, neuropathic pain, and pain related to multiple sclerosis are among the more frequently cited. Some patients have tried multiple medications over the years, experienced difficult side effects, and want something that gives them a bit of their life back without making them feel worse in other ways.
It’s also worth saying that not everyone who consults a specialist clinic ends up being prescribed cannabis-based medicine. A proper assessment means exactly that; reputable clinics will decline to prescribe if it’s not clinically appropriate, and that’s how it should work.
How Private Clinics Actually Work
Private medical cannabis clinics in the UK operate under a specific regulatory framework. Prescriptions can only be issued by a specialist consultant, not a GP. The consultant has to be on the GMC’s specialist register, and the prescriptions themselves go through a specially regulated pharmacy. So even though it’s private, it’s not a free-for-all. There’s real clinical oversight involved.
One clinic that’s become reasonably well known in this space is Medicann, which operates across the UK and focuses specifically on cannabis-based medicines for a range of qualifying conditions. They take patients through a structured consultation process, review their medical history, and work with specialists to determine whether a prescription is appropriate. The process isn’t instant, and it shouldn’t be.
Consultations typically happen online these days, which has made things significantly more accessible for patients who struggle with travel, either because of the conditions they’re dealing with or just because specialist services aren’t available close to where they live. A patient in rural Yorkshire doesn’t need to travel to London to see someone, which is a genuine practical difference from how a lot of specialist services work.
What It Actually Costs
This is where people often hit a wall. Medical cannabis prescriptions in the UK are not cheap. Depending on the product and dosage, monthly costs can run anywhere from around £150 to well over £400. That’s a significant ongoing expense, and it puts it out of reach for a lot of people who might otherwise benefit. There’s no getting around that, and it’s a real problem with how the current system is structured.
Some patients find the cost manageable relative to what they were spending on other treatments or private consultations for the same conditions. Others simply can’t sustain it. It’s an honest conversation worth having with any clinic before you go further, and any clinic that doesn’t bring it up unprompted probably should.
Is It the Right Route for Everyone
Almost certainly not. If your GP is managing your condition effectively and you’re doing reasonably well, there’s no obvious reason to go looking elsewhere. But for patients who’ve been through years of treatments that haven’t worked, or who’ve experienced side effects from conventional medications that have made things worse, it’s a route that’s at least worth understanding properly.
The information is out there. The question is whether the medical system does a good enough job of pointing people toward it when it’s actually relevant to them, and on that front, there’s still a fair amount of room for improvement.
